Stage IVB Prostate Cancer AJCC v8 Clinical Trials in Orland Park, Illinois

4 studies are recruiting for stage ivb prostate cancer ajcc v8 in Orland Park, Illinois right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

   This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from where it first started (primary site) to other places in the body. Cabozantinib may stop the growth of tumor cells by bl…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   University of Chicago Medicine-Orland Park, Orland Park, Illinois

   Locations

   581 in total

   Run by

   National Cancer Institute (NCI)

   See if you can join NCT03866382 on ClinicalTrials.gov

2. Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

   This phase III trial tests two questions by two separate comparisons of therapies. The first question is whether enhanced therapy (apalutamide in combination with abiraterone + prednisone) added to standard of care (prostate radiation therapy and short term androgen deprivation) is more effective c…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Northwestern Medicine Orland Park, Orland Park, Illinois

   Locations

   341 in total

   Run by

   ECOG-ACRIN Cancer Research Group

   See if you can join NCT04423211 on ClinicalTrials.gov

3. FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial

   This phase II trial compares the effect of FDG-positron emission tomography (PET)-guided metastasis directed radiation therapy (MDRT) in combination with standard treatments to standard treatments alone in treating patients with prostate cancer that is sensitive to androgen-deprivation therapy (ADT…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Northwestern Medicine Orland Park, Orland Park, Illinois

   Locations

   6 in total

   Run by

   Northwestern University

   See if you can join NCT06244004 on ClinicalTrials.gov

4. Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body

   This phase III trial compares the effect of adding carboplatin to the standard of care chemotherapy drug cabazitaxel versus cabazitaxel alone in treating prostate cancer that keeps growing even when the amount of testosterone in the body is reduced to very low levels (castrate-resistant) and that h…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Northwestern Medicine Orland Park, Orland Park, Illinois

   Locations

   174 in total

   Run by

   SWOG Cancer Research Network

   See if you can join NCT06470243 on ClinicalTrials.gov